EP 0731686 A1 19960918 - USE OF L-ARGININE, L-ORNITHINE OR L-CITRULLINE AND TOPICAL PREPARATIONS WITH THESE SUBSTANCES
Title (en)
USE OF L-ARGININE, L-ORNITHINE OR L-CITRULLINE AND TOPICAL PREPARATIONS WITH THESE SUBSTANCES
Title (de)
VERWENDUNG VON L-ARGININ, L-ORNITHIN ODER L-CITRULLIN UND TOPISCHEN ZUBEREITUNGEN MIT DIESEN STOFFEN
Title (fr)
UTILISATION DE L-ARGININE, DE L-ORNITHINE OU DE L-CITRULLINE ET PREPARATIONS TOPIQUES REALISEES A L'AIDE DE CES SUBSTANCES
Publication
Application
Priority
- DE 4341000 A 19931202
- EP 9403998 W 19941201
Abstract (en)
[origin: WO9515147A1] Disclosed is the use of one or more compounds selected from the group of L-arginine, L-ornithine and L-citrulline or their salts, acid addition salts, esters or amides, as needed with the addition of folic acid or its salts and/or one or more compounds selected from the group of flavins, for prophylaxis and/or treatment of neurosensory phenomena.
IPC 1-7
IPC 8 full level
A61K 8/00 (2006.01); A61K 8/04 (2006.01); A61K 8/30 (2006.01); A61K 8/40 (2006.01); A61K 8/42 (2006.01); A61K 8/44 (2006.01); A61K 8/49 (2006.01); A61K 8/67 (2006.01); A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61K 31/215 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); A61K 31/70 (2006.01); A61P 17/00 (2006.01); A61P 25/02 (2006.01); A61Q 17/04 (2006.01); A61Q 19/00 (2006.01); C07D 475/14 (2006.01)
CPC (source: EP)
A61K 8/44 (2013.01); A61K 8/67 (2013.01); A61K 31/195 (2013.01); A61K 31/505 (2013.01); A61K 31/70 (2013.01); A61P 17/00 (2017.12); A61P 25/02 (2017.12); A61Q 19/005 (2013.01)
Citation (search report)
See references of WO 9515147A1
Designated contracting state (EPC)
AT BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
DE 4341000 A1 19950608; EP 0731686 A1 19960918; JP H09505822 A 19970610; WO 9515147 A1 19950608
DOCDB simple family (application)
DE 4341000 A 19931202; EP 9403998 W 19941201; EP 95902780 A 19941201; JP 51540094 A 19941201